We have studied the effects of glucose on the release of somatostatin (SS),
Introduction

Materials and Methods
The role of glucose in mediating the altered patterns of growth hormone (GH) release in human arid animal diabetes is unknown. It may be indirect via changes in insulin-like growth factor feedback, or direct via alterations in tlze release of hypothalamic neuropeptides involved in the neuroregulation of GH. We have shown previously that increasing glucose concentrations inhibit basal hypothalamic somatostatin (SS), thyrotrophinreleasing hornlone (TRH) and GH-releasing hormone (GHRH) release from noririal rat hypothalami in vitro . The effects are specific, since the release of luteiiiizing hormone-releasing hormone is unaltered by glucose, and in broad agreement with the work ofnlost (Berelowitz et al. 1982 , Leng~el et al. 1986 , Baes & Vale 1990 ), but not all others (Richardson et al. 1983 , Yamaguchi et al. 1991 . Little is known about the influence of glucose on the release of these neuropeptides from the hypothalami of diabetic animals. In this study we have compared the effects of glucose on the release of' SS. T R H and G H R H from normal and diabetic rat hypothalami using the diabetic Goto-Kakizaki (GK) rat. The GK rat is a model of lion-obese diabetes niellitus, produced by selective inbreeding. These animals show mild basal hyperglycaeinia, hyperinsulinaemia, decreased pancreatic insulin stores, carbohydrate intolerance and a reduced insulin response to either oral (Goto et al. 1983 , Ismail et al. 1995 or intravenous (Portha et al. 1991) glucose challenge.
Animals
E
Nom~al male Wistar rats and male diabetic GK rats (also Wistar strain) from the University of Wales College of Medicine breeding colony were maintained in a thermostatically controlled room at 24 "C with a light period of 0700 to 1900 h. The animals were fed on a standard diet (Pilsbury's modified rat and mouse breeding diet). The GK rats were initially gifts from Professor Y Goto of Tohoku University School of Medicine, Sendai, Japan. Six breeding pairs were obtained in 1989 and a colony was established. The diabetic offspring were raised in parallel to the non-diabetic Wistar rats, which were used as controls. Rats were weaned 28 days after birth. T o assess the glucose tolerance of the rats, oral glucose (2 g/kg) was given to normal and diabetic animals ( n = j ) after a 12-h overnight fast and tail vein samples were taken for plasma glucose at 0, 30, 60, 90 and 120 min.
In vitro methodology I n vitro experiments were performed on hypothalaniic tissue removed from 9-week-old male GK and male control rats. Rats were fasted for 12 h and weighed before tissue removal. The method of in 11iri.o hypothalamic incubation has been described in detail previously . Briefly, the rats were decapitated with minimuni stress and the brains removed rapidly. Hypothalami, defined by the posterior margin of the optic chiasm and the anterior margin of the mamillary bodies to a depth of 2 mm, were dissected out, weighed, halved longitudinally and the two halves placed together in each well of a multiwell tissue culture plate containing 300 pl Krebs-Ringer bicarbonate solution with 0.1% (w/v) BSA, 5% glucose and bacitracin (300 pg/nil).
In previous studies we have demonstrated that basal release of SS, T R H and G H R H stabilises after incubation for 60 niin (authors' unpublished data). The hypothalami were therefore incubated for three successive 20-min periods and the media discarded. The experimental treatment was then applied for the final 20-min period. T o control for non-specific and osmolar effects on peptide release, we coinpared the effects of the active (D)-and the inactive (L)-isomers of glucose at each concentration tested. This methodological approach is important since we have previously demonstrated that even sn~all changes in the osmolarity of the incubation medium can exert significant effects on neuropeptide release . The medium was then removed, centrifuged and aliquoted for SS, T R H and G H R H assay. In the irz vitro studies each point represents the mean of at least four replicate wells and is typical of a mininium of three separate experiments.
Assays and data analysis
The ILIA procedures have been described previously . SS was measured by standard RIA using a fully characterised antiserum 693 (Pate1 & Keichlin 1978). Appropriate dilutions of labelled [ ' 2 5~-~y r ' ]~~ and antiserum were used to obtain 10 000 c.p.m. and 30% binding. Twenty-four hours of preincubation and incubation times were used at 4 "C and non-specifi c binding was 3-10.;,. Assay sensitivity was less than-l pg/tube and SS-14 and SS-28 compete on an equimolar basis for binding of label to this particular antibody (Scanlon et al. 1983 , Robbins et al. 1985 . T K H was also measured by a well-characterised RIA (Scanlon et al. 1983 ) which was set up as for SS. Twenty-four hours of preincubation and incubation times were used at 4 "C and non-specific binding was 1-2'%. Assay sensitivity was less than 0.5 pg/tube. Rat G H R H was measured using a two-site --imn~unochei~~iluminometric assay . In this assay, a C-terminal antibody was attached to a chemiluminescent probe and the N-terminal was attached to the solid p h a s e .~s s a~ sensitivity was 5 pg/ml and the coefficient of variation was less than 10% at dose levels of 0.5-100 pg. In each assay procedure a standard curve was set up in tubes containing the appropriate amount of solution. Plasma glucose was measured using the glucose oxidase method on a YSI model 2300 glucose analyser (Yellow Springs Instruments Ltd, Yellow Springs, O H , USA). All data are expressed as means + S.E.M. and statistical significance was determined at P<0.05.
Results
There was no significant difference between mean body weight (GK vs normal 249 + 3 vs 254 + 20 g) or hypothalamic weights (GK vs normal 41.1+2.2 vs 47.3 + 3.12 mg) in GK and normal rats. Fasting plasma glucose was significantly higher in all GK rats (GK vs nornlal8.8 + 0.3 vs 4.0 & 0.1 mM, P<0.001). After an oral glucose load (2 g/kg), there was an increase in plasma glucose concentrations in both GK (peak 17.5 & 1.0 mM at 30 niin) and nornial rats (peak 9.9 & 0.6 ~I M at 30 rnin). The mean glucose AUC was significantly higher in GK rats (P<0.001) (Fig. 1) .
At physiological concentrations (5 m~) of D-glucose, basal release of all three peptides was similar between normal and diabetic rats (normal vs diabetics 113 + 11.5 vs 118 + 11. . . effects of glucose are taken into account by using L-glucose as a control, significant differences emerge between normal and diabetic rats for each neuropeptide studied. A dose-related inhibitory action of D-glucose on SS release was present in both normal and diabetic hypothalami (Fig. 2a) . The data were analysed using one-way ANOVA followed by St~~dent-Newnlan-Keuls multiple conlparison test (normal and didbetic hypothalami 1 vs 5 ~I M , P<O.O01; 1 vs 25 mM, P<0.001; 5 vs 25 mM, NS).
However, the inhibitory action of D-glu~~Se on SS release was significantly less in diabetic than in normal hypothalami at 5 and 25 rnM concentration (%, release: 1 InM 87.8 + 9.0%1, NS vs normal; 5 mM 45.6 z t 4.50/;1, P<O.01 vs normal; 25 mM 35.7 + 6.2%), P<(J.(J2 vs normal; data were analysed using a non-paired Student's t-test).
A dose-related inhibitory action of D -~~U C O S~ on T R H release was also present (Fig. 2b) . Again, when the data were analysed by Student-Newman-Keuls multiple comparison test significant differences were observed (normal and diabetic hypothalalni 1 miv vs 5 mM, P<0.01; 1 n m vs 25 mM, P<(J.01; 5 IIIM vs 25 mM, NS). When the data were analysed using Student's t-test comparing diabetic with normal rats the inhibitory action of D-glucose on T R H was significantly less in diabetic than in normal hypothalanli at 5 and 25 rnM concentrations (0% release: 1 mM 100.7 + 13.696, NS vs normal; 5 mM 62.3 + 2,396, P<O.001 vs normal; 25 mM 51.6 + 5.1?4, P<O.Ol vs normal).
D-glucose also showed a dose-related inhibition of G H R H from normal hypothalami over a 20-min period (Fig. 2c ). Data were analysed by Student-Newman-Keuls test (1 vs 5 mM, P<0.001; 1 vs 25 mM, P<O.001; 5 vs 25 mM, P<0.01). However, in contrast to the results obtained for SS and T R H , D-gl~lCose did not inhibit GHKH release from diabetic hypothalami. When the results were analysed using Student's f-test there was a significant difference in release from normal hypothalanli 
Discussion
The GK rats used in this study showed fasting hyperglycaemia and impaired glucose tolerance although body weight was normal. Basal release of T R H , SS and G H R H was unchanged in GK rats compared with nom~al rats at physiological glucose concentrations (5 nlM D-glucose) which contrasts with some previous data. Twente (1987) reported that SS release from dispersed adult hypothalamic cells of STZ-treated rdts was diminished both basally and after stimulation by membrane depolarisation. In contrast. Joanny et al. (1992) showed an increase in SS release frotn incubated hypothalamic slices from STZ-treated diabetic rats.
workers have suggested that this increase in SS release, associated with a decrea~e in hypothalamic G H R H mRNA content reported elsewhere (Olchovsky et a/. 1990 ), may contribute to the decreased G H secretion found in diabetic rats (Harrison & Robinson 1980 , Tannenbaum 1981 , Gonzalez & Jolin 1985 . Joanny et al. 1992 . Possible explanations for these observed differences include variations in body weight, severity of diabetes and type of animal model used and, with regard to the latter, it should be remembered that the actions of STZ are not confined to the P-cell (Pate1 et al. 1978) . However, these data should be treated cautiously since basal neuropeptide release from isolated hypothalami inay not be a reliable reflection of in vivo events.
Despite these conflicting data regarding basal neuropeptide release we have confirmed the potent effects of glucose on hypothalamic peptide release (Berelowitz et al. 1982 , Lengyel et al. 1986 , 1988 , Baes & Vale 1990 . Active D-glucose can be viewed ac exerting a biphasic action around the physiological concentration of 5 1 1 1~ with release of SS, T R H and G H R H beingstimulated at concentrations below 5 mM and inhibited at concentrations above 5 mM. It is possible that different mechanisnls mediate these actions and preliminary data indicate that the peptide-releasing effects of glucose concentrations less than 5 m~ are mediated by glutatnate pathways (Lewis et al. 1992 , Sato & Frohman 1993 as are other neurological responses to hypoglycaemia (Tasker et al. 1992) . Whether the inhibitory action of glucose concentrations above 5 m~ reflects a direct action of glucose on peptidergic neurones is unknown at present.
The effect of low glucose on G H R H release in nonnal rats is controversial. While the results of Baes & Vale (1 990) are in agreement with ours, Frohman et al. ( 1 990) did not show parallel increases in G H R H and SS release in hypophysial portal blood of sheep in response to insulininduced hypoglycaemia. Furthermore, Murao et al. (1994) reported that rat hypothalamic SS IIIRNA levels were increased dramatically by hypoglycaernia whereas G H R H mRNA levels were unaffected. These discrepancies may be due to the different methods involved in G H R H detection, species variation and the difference in experimental techniques or a combination of all these.
In GK, in contrast to normal hypothalami, the effects of D-glucose on neuropeptide release were significantly different: with regard to SS and T R H , the effects of glucose concentrations below and above 5 InM were significantly reduced whilst the effects of glucose on G H R H were totally abolished in the presence of isosmolar concentrations of I.-glucose. It appears therefore that these peptidergc neurones become differentially desensitised to the effects of glucose ( G H R H > T R H and SS) in the presence of diabetes mellitus. Consequent changes in the in vivo pattern of neuropeptide release could contribute to the altered G H secretion which occurs in GK rats (Ismail et al. 1995) and in other hyperglycaemic rat models (Tannenbaum 198 1, Tannenbaum et 01. 108 1, Locatelli et al. 1985 , Ndon et al. 1992 , although the precise mechanisnis are unknown at present.
In conclusion, we have shown that the sensitivity of GHRH-, SS-and TRH-producing hypothalamic neurones to glucose is markedly reduced in diabetic GK rats with a particularly pronounced loss of sensitivity by G H R H peptidergic neurones. The mechanisms underlying these effects are unknown but it appears that the diabetic state reduces the sensitivity of hypothalainic neurones to subsequent changes in glucose concentrations. This could be via alterations in neurotransmitter control of peptidergic neurones and/or reduction in hypothalamic glucose transporter number or function. Our subsequent studies will address these issues.
